blog
Blog
Forging a Path Forward for Substance Abuse Potential Studies With the Cross-Company Abuse Liability Council By Beatrice Setnik, PhD
Beatrice Setnik, PhD, discusses the mission of CCALC, the importance of abuse potential studies, and challenges in evaluating psychedelics for clinical use.
Blog
Regulatory Guidance for Oligonucleotide Bioanalysis in Drug Development
Discover FDA guidances for oligonucleotide bioanalysis, safety assessments, and clinical pharmacology, and how Altasciences supports regulatory-compliant drug development.
Blog
Top Life Science Resources for Fall 2024
Discover 10 life science resources that you may have missed from Altasciences in 2024, including case studies, webinars, podcasts, posters, and videos!
Blog
Exploring the Advantages of Canada for Early-Phase Clinical Trials
Explore Canada `s advantages for early-phase clinical trials: streamlined regulatory pathways, diverse participant pool, and cost-effectiveness.
Blog
Top 10 Life Science Resources - October 2023
Discover expert insights, tips, guidances and more resources, that you may have missed since our last recap
Blog
Drug Development Timelines: How Health Canada’s 30-Day Regulatory Review Process Could Provide an Advantage
The EMA recently updated their clinical trial application process. Discover how Health Canada's CTA process compares.
Blog
Five Reasons to Choose Canada for Your Clinical Trials—From the Webinar Demystifying the Conduct of Clinical Trials in Canada
Five advantages of conducting clinical trials in Canada. Read this overview to find out more.